Western Biotech’s “DeepSeek Moment” – China’s Rise in Pharma Innovation.
A WSJ artivcle >>> https://lnkd.in/eSua5PBt The WSJ article opens with how Summit Therapeutics’ cancer drug, licensed from China’s Akeso, outperformed Merck’s $30B Keytruda. But apparently this isn't all that special — Chinese companies now account for 31% of major pharma licensing deals, up from just 5% in 2020. Why Chinese Biotech Is Winning ✅ Lower costs & streamlined clinical trials ✅ Lean operations with minimal bureaucracy ✅ Better drug candidates at lower prices ✅ Faster R&D with Wuxi and other CDMOs driving efficiency Source: Rui Ma 马睿 on X, WSJ
BREAKING: Beginning Monday, China will implement tariffs of up to 15% on $14 billion in U.S. exports, including LNG, coal, crude oil, farm equipment, and select vehicles.
Looks like China is fighting back against Trump's 10% tariffs on Chinese imports that he announced last week... Source: Financial Times
China's retaliatory tariff will hit the United States today.
Here is how the U.S Corporations and consumers will be impacted. Source: Unicus @UnicusResearch
Xi’s Reply to Trump Tariffs Shows China Has More to Lose - Bloomberg
https://lnkd.in/ez4qCpZa Source: Bloomberg thru C.Barraud
BREAKING: China has opened antitrust investigations into Nvidia and Google just hours after imposing 10%-15% tariffs on some US imports, per FT.
China is reportedly looking for new trade war leverage against President Trump. Source: FT
Visualizing the Rise in Global Coal Consumption ⚡️
Source: Elements
Apple Slides After iPhone Sales Miss, China Revenues Unexpectedly Tumble
The one - very big - fly in the ointment was the usual suspect: China, where revenues unexpectedly tumbled, sliding a whopping 11%, and badly missing estimates of a $21.57BN print Greater China rev. $18.51 billion, -11% y/y, estimate $21.57 billion Source: zerohedge.com
Chinese debt pile is GIGANTIC: China's total debt to GDP rose to a RECORD of ~370%.
The share has DOUBLED over the last 14 years. This does not include shadow banking (outside traditional banking sector). China has a massive debt problem and it will not go away soon. Source: Apollo, Bloomberg, Global Markets Investor
